PEOPLE - Changes at Novartis (Switzerland)
This article was originally published in Clinica
Executive Summary
Daniel Vasella, CEO of Novartis, is to succeed Alex Krauer as chairman of the Swiss pharmaceutical company. Dr Krauer is to retire in April but will remain honourary chairman.